|
Lofepramine,抑制剂
|
L287104-50mg
|
Moligand™, ≥97% |
23047-25-8 |
50mg
|
¥ 2329.9
|
现货 |
|
0 |
阿拉丁 |
|
Lofepramine,抑制剂
|
L287104-10mg
|
Moligand™, ≥97% |
23047-25-8 |
10mg
|
¥ 843.9
|
现货 |
|
0 |
阿拉丁 |
|
L 760735,NK1拮抗剂
|
L287080-50mg
|
Moligand™, ≥99%(HPLC) |
188923-01-5 |
50mg
|
¥ 10815.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
L 760735,NK1拮抗剂
|
L287080-10mg
|
Moligand™, ≥99%(HPLC) |
188923-01-5 |
10mg
|
¥ 2720.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
L-叠氮高丙氨酸盐酸盐
|
L287058-10mg
|
≥97% |
942518-29-8 |
10mg
|
¥ 119.9
|
现货 |
|
0 |
阿拉丁 |
|
LP 922056,Notum抑制剂
|
L287036-50mg
|
≥98%(HPLC) |
1365060-22-5 |
50mg
|
¥ 3609.9
|
现货 |
|
0 |
阿拉丁 |
|
LP 922056,Notum抑制剂
|
L287036-10mg
|
≥98%(HPLC) |
1365060-22-5 |
10mg
|
¥ 1139.9
|
现货 |
|
0 |
阿拉丁 |
|
Lazabemide盐酸盐
|
L287023-50mg
|
≥98%(HPLC) |
103878-83-7 |
50mg
|
¥ 2131.9
|
现货 |
|
0 |
阿拉丁 |
|
Lazabemide盐酸盐
|
L287023-10mg
|
≥98%(HPLC) |
103878-83-7 |
10mg
|
¥ 639.9
|
现货 |
|
0 |
阿拉丁 |
|
L-168,049,人胰高血糖素受体拮抗剂
|
L287004-50mg
|
Moligand™, ≥99%(HPLC) |
191034-25-0 |
50mg
|
¥ 6896.9
|
现货 |
|
0 |
阿拉丁 |
|
L-168,049,人胰高血糖素受体拮抗剂
|
L287004-10mg
|
Moligand™, ≥99%(HPLC) |
191034-25-0 |
10mg
|
¥ 1623.9
|
现货 |
|
0 |
阿拉丁 |
|
L-DON,谷氨酰胺酶抑制剂
|
L287002-5mg
|
≥98% |
157-03-9 |
5mg
|
¥ 2699.9
|
现货 |
|
0 |
阿拉丁 |
|
LDN 27219,转谷氨酰胺酶2(TG2)抑制剂
|
L286972-50mg
|
≥99%(HPLC) |
312946-37-5 |
50mg
|
¥ 5038.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LDN 27219,转谷氨酰胺酶2(TG2)抑制剂
|
L286972-10mg
|
≥99%(HPLC) |
312946-37-5 |
10mg
|
¥ 1182.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
L-AP5,NMDA拮抗剂
|
L286955-50mg
|
≥99%(HPLC) |
79055-67-7 |
50mg
|
¥ 9456.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
L-AP5,NMDA拮抗剂
|
L286955-10mg
|
≥99%(HPLC) |
79055-67-7 |
10mg
|
¥ 2297.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LFM-A13,BTK抑制剂
|
L286934-50mg
|
≥98%(HPLC) |
62004-35-7 |
50mg
|
¥ 1564.9
|
现货 |
|
0 |
阿拉丁 |
|
LFM-A13,BTK抑制剂
|
L286934-10mg
|
≥98%(HPLC) |
62004-35-7 |
10mg
|
¥ 526.9
|
现货 |
|
0 |
阿拉丁 |
|
LG 100754,RXR:PPAR激动剂
|
L286924-50mg
|
Moligand™, ≥98% |
180713-37-5 |
50mg
|
¥ 6756.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LG 100754,RXR:PPAR激动剂
|
L286924-10mg
|
Moligand™, ≥98% |
180713-37-5 |
10mg
|
¥ 1668.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LRGILS-NH2 TFA
|
L286899-1mg
|
≥98% |
245329-01-5 |
1mg
|
¥ 479.9
|
现货 |
|
0 |
阿拉丁 |
|
LDN 212854,I型强骨形态发生蛋白(ALK)抑制剂
|
L286865-50mg
|
≥98%(HPLC) |
1432597-26-6 |
50mg
|
¥ 3810.9
|
现货 |
|
0 |
阿拉丁 |
|
LDN 212854,I型强骨形态发生蛋白(ALK)抑制剂
|
L286865-10mg
|
≥98%(HPLC) |
1432597-26-6 |
10mg
|
¥ 1065.9
|
现货 |
|
0 |
阿拉丁 |
|
L-732,138,NK1拮抗剂
|
L286835-50mg
|
Moligand™, ≥98%(HPLC) |
148451-96-1 |
50mg
|
¥ 574.9
|
现货 |
|
0 |
阿拉丁 |